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I ~  Excimer Laser in the Treatment of Angioplasly 
Instant RsstenoMs: An Intravascuiar Ultrasound 
Study 
Roxana Mehren, Gary S. Mintz, Jeffrey J. Popma, Augusto D. Pioherd, 
Lowell F. Sailer, Kenneth M. Kent, S. Chlu Wong, Martin B. Leon. 
Washington Haspitat Center, Washington, DC 
Treatment of instant restenosls using PTCA extrudes some neolntimal tissue 
out of the stsnt and redistributes the residual tissue over a greater slant 
cl,-cumference (post-repeat PTCA). Alternatively, we used excimer laser an- 
gioplasty (ELCA) to ablate neointimal tissue prior to repeat PTCA (especially 
in longer or more severe restenotic lesions) and assessed the results using 
intravaScular ultrasound {IVUS: measurement of stenL lumen, and intimal 
hyperplasia areas (mm~)} before ELCA and after adjunctive PTCA. 
Pre-intervonrion Post ELCA + PTCA p 
Slant area 7.2 ± 2.1 8.4 ± 2.3 < 0.0001 
Lumen area 1.6 :l: 0.8 6.4 ± 1.7 < 0.0001 
Inttma! hyperplasia area 53±2.3 2.0~1.3 < 0.0001 
The 30 restenntic stents treated with ELCA + PTCA were then compared 
to 45 restenotic slants treated with PTCA alone. Despite longer lengths of 
neointima[ tissue within the stents (17.8 4- 9.9 vs 13.1:1:10,0 ram, p = 
0.0662), the combination of ELCA + PTCA resulted in (1) a greater lumen 
gain (3.9 .;- 2.2 vs 2.5 4- 3.5 mm 2, p = 0.0640), (2) a greater decrease in 
intimal hyperplasia distributed within the stent (2.2 4- 2.0 vs 0.6 • 3.t mm 2, 
p = 0.0249), and (3) less residual intimal hyperplssia within the stent (2.2 :t: 
1.4 vs 3.2 4- 2.4 tarrY, p = 0.0431). We conclude: ELCA offerS an attractive 
alternative to PTCA for the treatment of instant restenosis, particularly severe 
diffuse instsnt restenosis with a large burden of neointimal tissue. Rather 
than extruding tissue out of the slant or redistributing tissue over a greater 
stent alrcumference, ELCA appearS to ablate (is., remove) neointimal tissue 
facilitating adjunctive PTCA. 
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' Analysis o! Instant  Restenosis 
Gaston R. Dussalilant, Gary S. Mintz, Augusto D. Pichard, Kenneth 
M. Kent, Lowell R Seller, Jeffrey J. Popma, Paul Mackel, Caret Welsh, S. 
Chlu Wong, Carolyn Ewels, Ann Greenberg, Theresa Bucher, Martin 
B. Leon. Washington Hospital Center, Washington DC 
We pedormed serial volumetric intrevascular ultrasound analysis {IVUS post- 
intervention and at follow-up (F/U) @ 3.9 4-1.8 months) in 32 native coronary 
and 9 vein grail lesions treated with 52 Palmaz-Schatz slants and adjunctive 
high-pressure PTCA (15~5 4- 3.7 arm). Motorized transducer pullback @ 0.5 
mm/sec through a stationary imaging sheath permitted measutements of 
stent and lumen areas in 2 mm axial increments and calculation of slant, 
lumen, and neointimal hyperplasia (slant-lumen) volumes (in mm ~) using 
SImpsan's rule. Overall, stent volume was 131 4- 72 romp post-PTCA and 
did not change at F/U, Lumen volume decreased from 129 -~ 71 rnm s post- 
PTCA to 88 4- 67 mm ~ (p < 0.0001) at FJU, due to the accumulation of 43 
26 mn~ of neointimal tissue/slant. A comparison of 24 restenotic and 17 
nenrestenotlo lesions showed: 
No restenos=s ~es',enos~e p 
POst-PTCA slant volume 169 :t: 80 103 ~: 52 0,0029 
POSt.PTCA lumen volume 107 - 80 102 ~ 50 0.0027 
F/U slant volume 169 ± 80 104 ~ 52 0.0028 
F/U lumen volume 134 ± 69 54 :I: 40 < 0,0001 
& slant volume 0 ± 3 0 ~ 2 NS 
Intima! hyperplasla volume 34 :t: 22 50 .~ 27 0,066 
We conclude: Sedal volumetric iVUS analysis shows that intimal hyper- 
plasia causes In-stent restenosis. Regardless of lesion location (native vs 
SVG), stsnt compression does not occur as there is no chronic decrease in 
slant volume even in restenotl¢ slants. 
• Oetenninatlon of the Mechanisms Responsible 
for stent Rsstenosls: A Quantitative 
Angiogrephlc Study 
Gl!berto Nunes, Fausto Feros, Galo Maldonado, Luiz Tanajura, Luiz Mattos, 
Ibraim Pinto, Aurae Cheves, Marinella Centemero, Amanda Souse, J. 
Eduardo Sousa. Institute Dante Pazzanese of Cardiology, S~o Paulo, Brazil 
The purpose of this study was to determine the relative contribution of 
three distinct mechanisms [elastic recoil (REC), slant compr~ssicn (SC), 
and Intimal hyperplasia (IH)] in the late lumen loss that follows co~nary 
slant implantation. Eighty pts who underwent elective or emergency Palmaz- 
Schatz stent placement and had a late angiogram performed were evaluated. 
Repeat catheterization was performed due to completion of the follow-up 
period (6 month) or evidence of recurrent ischemla. The paired anglogrems 
(initial and follow-up} were analyzed by quantitative coronary angiography 
using an automated edge-detection algorithm. Twenty-two pts developed 
restenosis at the slanted site (> 50% stenosis). The following angiogrephic 
measurements were performed after slanting and at follow-up: reference 
vessel diameter (RD), elastic recoil (REC), minimal lumen diameter (MLD}, 
and slant diameter (SD, vessel free of contrast). Values are expressed in 
ram" 
After 8tenting Follow.up REC SC IH 
MLD SD MLD SO 
WithoutRE 3.5:E0.4 3,6d:0.42.9:E0.S3.3:E0,4-0.4:E8.2 0,2±0,20.4~0.5 
WithRE 3.3:E0,4" 3,5:E0.4 1,4-~0.73,2~0.3 4.44-8.4* 0.:)~0.1 1.8:1:0,0" 
*p < 0,05 compared to Without RE 
On average, IH was responsible for 7lP/o of the late loss in the w~thout RE 
greup and 97% in the with RE group. We conclude that intimal proliferation is 
the major mechanism off late lumen loss (and cons*quently, restenosis) after 
Palmaz-Schatz slant implantation. Elastic recoil and stent compression play 
a minor role in the renarrowing process (although the former is significantly 
greater in pts with restanosis), 
~ Radiat ion Parameters Assoc iated With Coronary 
Irradiat ion Pilot Study to Inhibit  Restenos is  After 
Slant ing 
Shirish K. Jeni, Vincent Maasuilo, Prabhakar Tripuraneni, Paul S. Teirstein, 
Steve Steuterman, Haoran Jin, Stephanie Degenkolb. Scripps Clinic and 
Research Foundation, La Julia, CA 
Restenosis is a meier problem associated with coronary balloon angioplasty 
as well as slant implantation. Low dose brachy radiotherapy immediately 
after stenting may reduce the restenosis rate. To examine this issue, a pilot 
study has been launched to deliver localized radiation to the stented vessel 
with the use of radioactive Ir-192 sources, Ir-192 decays with a hall life 
of 74 days by emitting 350 keV x-rays, The sources were in the form of 
cylindfloal seeds (0.3 cm x 0.05 cm) and were imbedded in a nylon ribbon 
of _< 0.08 cm in diameter. The ribbon had either 5 or 9 seeds with a spacing 
of 0.1 cm to allow flexibility needed for o'lthetefization. A probing catheter 
(0.135 cm CO) was utilized to guide the radioactive ribbon to the implanted 
Palmaz-Schatz slant(s). A minimum radiation dose of approximately 800 
centiGray (cGy) was delivered to the atheresclerotic lesion while keeping 
the maximum tissue dose at < 3000 cGy. Treatment ime depended upon 
the radioactive strength of the Ir-tg2 seeds and was in the range of 20--40 
minutes. The radiation dose distribution around our ribbon was analyzed by 
using film dasimetry and thermoluminescent dosimeters. Also, we examined 
radiation exposure levels in and around the cethetedzation rooms during the 
radiation procedure. By utilizing portable radiation shields, we were able to 
reduce room radiation levels to well below 2 mR/hr limit set by regulatory 
agencies for non-occupational exposure. Our experience with 30 patients to 
date indicates this is a sate procedure with no eady adverse effects. 
Angioplasty and Restenosis: Markers 
Wednesday, March 27, 1996, Noon-2:00 p.m. 
Orange County Convention Center, Hall E 
Presentation Hour: Noon-1:00 p.m. 
~ Llpoprotein(a) Concentration Does Not 
Correlate With Angiographic Restenoais 
Francis Ergina, Gilles C8~, Antonio Ciampi, Bruno Farrah, Serge Doucet, 
Luo Biico~au, Jean-Claude Tardif, Raoul eonan, Bela Charles Solymoss. 
Montreal Heart Institute, Montreal, Quebec, Canada 
Background: Although some research groups have reported a good corm- 
